Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Crespo

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Trials|April 6, 2017
Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trialAna Moreno-Alcázar, Joaquim Radua, Ramon Landín-Romero, et al.
The Lancet. Infectious Diseases|June 12, 2015
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trialJosé R Arribas, Pierre-Marie Girard, Roland Landman, et al.
The Journal of Antimicrobial Chemotherapy|November 8, 2008
Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohortManuel Crespo, Esteban Ribera, Ignacio Suárez-Lozano, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2021
Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretionMaria Jesus Perez Elias, Belen Alejos, Maria Mar Gutierrez, et al.
JAMA|March 14, 2022
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 29, 2016
Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorderIsabella Pacchiarotti, Jordi León-Caballero, Andrea Murru, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2014
Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptomsBrisa Solé, C Mar Bonnin, María Mayoral, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 28, 2016
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.
The New England Journal of Medicine|October 27, 2021
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody SotrovimabAnil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, et al.
Acta Psychiatrica Scandinavica|September 7, 2024
The impact of sex in the effectiveness of functional remediation in bipolar disorderMaria Serra-Navarro, Derek Clougher, Brisa Solé, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Trials|April 6, 2017
Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trialAna Moreno-Alcázar, Joaquim Radua, Ramon Landín-Romero, et al.
The Lancet. Infectious Diseases|June 12, 2015
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trialJosé R Arribas, Pierre-Marie Girard, Roland Landman, et al.
The Journal of Antimicrobial Chemotherapy|November 8, 2008
Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohortManuel Crespo, Esteban Ribera, Ignacio Suárez-Lozano, et al.
The Journal of Antimicrobial Chemotherapy|January 27, 2021
Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretionMaria Jesus Perez Elias, Belen Alejos, Maria Mar Gutierrez, et al.
JAMA|March 14, 2022
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 29, 2016
Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorderIsabella Pacchiarotti, Jordi León-Caballero, Andrea Murru, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 8, 2014
Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptomsBrisa Solé, C Mar Bonnin, María Mayoral, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 28, 2016
Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsAntonio Rivero, José Antonio Pérez-Molina, Antonio Javier Blasco, et al.
The New England Journal of Medicine|October 27, 2021
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody SotrovimabAnil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, et al.
Acta Psychiatrica Scandinavica|September 7, 2024
The impact of sex in the effectiveness of functional remediation in bipolar disorderMaria Serra-Navarro, Derek Clougher, Brisa Solé, et al.
Pageof 12